President Donald Trump is set to appear on CNBC’s “Squawk Box” for a live interview at 8:30 a.m. ET today, as stock futures show signs of recovery following a down day for Wall Street. Here are five critical updates for investors to kick off the trading day.
In a surprising announcement, Apple has revealed that John Ternus, the company’s current hardware chief, will replace Tim Cook as CEO in September. Cook will transition to the role of executive chairman. This decision has caught many investors off guard; however, some see Ternus’ hardware background as a positive move. Analysts highlight a key challenge for Ternus: addressing Apple’s perceived shortcomings in artificial intelligence compared to its major industry peers. In after-hours trading, Apple shares have dipped slightly, putting its modest gains for 2026 at risk. Under Cook’s leadership since 2011, Apple’s stock has skyrocketed over 1,930%.
In Washington, Kevin Warsh, Trump’s nominee to chair the Federal Reserve, faces the Senate Banking Committee for his confirmation hearing today. Warsh has stated that the Fed must maintain its independence from political influences while acknowledging the importance of resisting pressure to lower interest rates. He is likely to encounter questions regarding his ties to Silicon Valley and his personal wealth, particularly from Senator Thom Tillis, who has pledged not to support Warsh until investigations into current Fed chair Jerome Powell are settled.
On the market front, the Nasdaq Composite ended its longest winning streak since 1992 in a downturn marked by geopolitical tensions, particularly Trump’s military threats to Iran. Meanwhile, small-cap stocks showcased resilience as the Russell 2000 reached new highs during the session.
Shares of UnitedHealth Group have surged more than 7% after reporting an impressive first-quarter performance that exceeded expectations. The company has raised its earnings outlook for 2026, aided by improved management of medical costs. A notable decrease in the medical benefit ratio, which indicates better margins for insurers, has buoyed investor confidence. This surge follows strong gains earlier in April due to favorable government adjustments in payment rates for Medicare Advantage plans.
Finally, excitement surrounds the psychedelics sector following Trump’s executive order aimed at accelerating research and accessibility for substances such as psilocybin and MDMA. Stocks like Compass Pathways soared 42%, while AtaiBeckley experienced a 21% increase, marking their most significant daily gains. Analysts question whether the psychedelics market will encounter similar regulatory hurdles as the cannabis sector, with one legal expert noting that the governmental review process can be slow and cumbersome.
In regulatory news, U.S. importers are potentially looking at over $160 billion in tariff refunds following the Supreme Court’s recent decision that invalidated many of Trump-era tariffs imposed in February. Major retailers are projected to benefit significantly from these refunds.
Stay updated with the latest market trends and insights directly through CNBC.
